Virbac SA (EPA:VIRP) Investors Are Less Pessimistic Than Expected
May 18
Have your own idea? Try our Stock Screener
French (CAC) Pharma Industry Analysis
UpdatedJun 03, 2025
DataAggregated Company Financials
Companies6
- 7D-6.5%
- 3M-19.7%
- 1Y-5.9%
- YTDn/a
Over the last 7 days, the Pharma industry has dropped 4.1%, driven by Sanofi declining 5.0%. In contrast, Virbac has gained 8.5%. However, the industry is down 4.0% over the past year. Earnings are forecast to grow by 12% annually.
Industry Valuation and Performance
Has the French Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 03 Jun 2025 | €117.6b | €52.1b | €6.7b | 19.1x | 17.7x | 2.3x |
| Thu, 01 May 2025 | €129.9b | €52.1b | €6.7b | 18.9x | 19.5x | 2.5x |
| Sat, 29 Mar 2025 | €139.6b | €51.2b | €5.9b | 18.2x | 23.5x | 2.7x |
| Mon, 24 Feb 2025 | €143.8b | €51.2b | €5.8b | 18.5x | 24.9x | 2.8x |
| Wed, 22 Jan 2025 | €137.5b | €55.2b | €5.1b | 18.3x | 27x | 2.5x |
| Fri, 20 Dec 2024 | €127.8b | €55.2b | €5.1b | 19.3x | 25.1x | 2.3x |
| Sun, 17 Nov 2024 | €127.9b | €55.2b | €5.1b | 20.6x | 25.1x | 2.3x |
| Tue, 15 Oct 2024 | €140.1b | €53.8b | €4.8b | 22.6x | 29.2x | 2.6x |
| Thu, 12 Sep 2024 | €144.8b | €53.8b | €4.8b | 20.1x | 30.2x | 2.7x |
| Sat, 10 Aug 2024 | €134.0b | €53.8b | €4.8b | 20x | 27.9x | 2.5x |
| Mon, 08 Jul 2024 | €127.8b | €52.9b | €5.2b | 20.1x | 24.7x | 2.4x |
| Wed, 05 Jun 2024 | €128.0b | €52.9b | €5.2b | 21.4x | 24.7x | 2.4x |
| Fri, 03 May 2024 | €129.2b | €52.9b | €5.2b | 20.3x | 24.9x | 2.4x |
| Sun, 31 Mar 2024 | €127.6b | €52.7b | €6.0b | 21x | 21.1x | 2.4x |
| Tue, 27 Feb 2024 | €125.4b | €52.6b | €6.3b | 20.2x | 20x | 2.4x |
| Thu, 25 Jan 2024 | €130.4b | €52.2b | €9.7b | 20.4x | 13.4x | 2.5x |
| Sat, 23 Dec 2023 | €126.3b | €52.2b | €9.7b | 18.9x | 13x | 2.4x |
| Mon, 20 Nov 2023 | €121.1b | €52.2b | €9.7b | 16.9x | 12.5x | 2.3x |
| Wed, 18 Oct 2023 | €144.5b | €52.6b | €9.3b | 17.5x | 15.6x | 2.7x |
| Fri, 15 Sep 2023 | €144.4b | €52.6b | €9.3b | 18.9x | 15.6x | 2.7x |
| Sun, 13 Aug 2023 | €137.1b | €52.6b | €9.3b | 21.5x | 14.8x | 2.6x |
| Tue, 11 Jul 2023 | €131.8b | €52.6b | €9.1b | 17.6x | 14.4x | 2.5x |
| Thu, 08 Jun 2023 | €132.9b | €52.6b | €9.1b | 15.5x | 14.5x | 2.5x |
| Sat, 06 May 2023 | €141.4b | €52.6b | €9.1b | 15.6x | 15.5x | 2.7x |
| Mon, 03 Apr 2023 | €138.8b | €51.8b | €9.2b | 15.4x | 15.2x | 2.7x |
| Wed, 01 Mar 2023 | €125.4b | €51.7b | €9.2b | 17.4x | 13.7x | 2.4x |
| Fri, 27 Jan 2023 | €125.6b | €50.7b | €7.4b | 18.5x | 17.1x | 2.5x |
| Sun, 25 Dec 2022 | €127.3b | €50.7b | €7.4b | 17.1x | 17.3x | 2.5x |
| Tue, 22 Nov 2022 | €123.8b | €50.7b | €7.4b | 16.9x | 16.8x | 2.4x |
| Thu, 20 Oct 2022 | €115.6b | €48.4b | €7.6b | 16.8x | 15.2x | 2.4x |
| Sat, 17 Sep 2022 | €116.7b | €48.2b | €7.6b | 19x | 15.4x | 2.4x |
| Mon, 15 Aug 2022 | €121.8b | €48.2b | €7.6b | 23.1x | 16.1x | 2.5x |
| Wed, 13 Jul 2022 | €139.9b | €46.3b | €7.5b | 23.1x | 18.7x | 3x |
| Fri, 10 Jun 2022 | €136.7b | €46.3b | €7.5b | 22.4x | 18.2x | 3x |
Price to Earnings Ratio
18.2x
Current Industry PE
- Investors are relatively neutral on the French Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 19.4x.
- The industry is trading close to its 3-year average PS ratio of 2.5x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 3.9% per year over the last three years.
- Meanwhile revenues for these companies have grown 4.0% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does French Pharma compare with similar industries?
| FR Market | -0.85% | |
| Healthcare | -4.30% | |
| Pharma | -6.50% | |
| Pharma | -6.50% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| IPN Ipsen | €104.90 | 1.9% +€165.4m | -13.5% | PE24.4x | |
| VIRP Virbac | €332.00 | 2.5% +€67.0m | -5.3% | PE19.1x | |
| VETO Vetoquinol | €75.30 | 3.4% +€29.5m | -25.1% | PE15.1x | |
| MLCOT Coretech 5 Société anonyme | €0.063 | 24.8% +€167.6k | 215.0% | PE40.1x |